Solchaga Luis A, Temenoff Johnna S, Gao Jizong, Mikos Antonios G, Caplan Arnold I, Goldberg Victor M
Department of Orthopaedics, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, OH, USA.
Osteoarthritis Cartilage. 2005 Apr;13(4):297-309. doi: 10.1016/j.joca.2004.12.016.
The natural repair of osteochondral defects can be enhanced with biocompatible, biodegradable materials that support the repair process. It is our hypothesis that hyaluronan-based scaffolds are superior to synthetic scaffolds because they provide biological cues. We tested this thesis by comparing two hyaluronan-based scaffolds [auto cross-linked polysaccharide polymer (ACP) and HYAFF-11] to polyester-based scaffolds [poly(DL-lactic-co-glycolic acid) (PLGA) and poly(L-lactic acid) (PLLA)] with similar pore size, porosity and degradation times.
Fifty-four rabbits received bilateral osteochondral defects. One defect received a hyaluronan-based scaffold and the contralateral defect received the corresponding polyester-based scaffold. Rabbits were euthanized 4, 12 and 20 weeks after surgery and the condyles dissected and processed for histology.
Only ACP-treated defects presented bone at the base of the defect at 4 weeks. At 12 weeks, only defects treated with rapidly dissolving implants (ACP and PLGA) presented bone reconstitution consistently, while bone was present in only one third of those treated with slowly dissolving scaffolds (HYAFF-11 and PLLA). After 20 weeks, the articular surface of PLGA-treated defects presented fibrillation more frequently than in ACP-treated defects. The surface of defects treated with slowly dissolving scaffolds presented more cracks and fissures.
The degradation rate of the scaffolds is critical for the repair process. Slowly dissolving scaffolds sustain thicker cartilage at the surface but, it frequently presents cracks and discontinuities. These scaffolds also delay bone formation at the base of the defects. Hyaluronan-based scaffolds appear to allow faster cell infiltration leading to faster tissue formation. The degradation of ACP leads to rapid bone formation while the slow degradation of HYAFF-11 prolongs the presence of cartilage and delays endochondral bone formation.
生物相容性、可生物降解的材料能够支持骨软骨缺损的修复过程,从而增强其自然修复能力。我们的假设是,基于透明质酸的支架优于合成支架,因为它们能提供生物信号。我们通过比较两种基于透明质酸的支架[自交联多糖聚合物(ACP)和HYAFF-11]与具有相似孔径、孔隙率和降解时间的聚酯基支架[聚(DL-乳酸-共-乙醇酸)(PLGA)和聚(L-乳酸)(PLLA)]来验证这一论点。
54只兔子接受双侧骨软骨缺损手术。一侧缺损植入基于透明质酸的支架,对侧缺损植入相应的聚酯基支架。术后4周、12周和20周对兔子实施安乐死,解剖髁并进行组织学处理。
术后4周,仅ACP处理的缺损在缺损底部出现骨组织。术后12周,只有用快速溶解植入物(ACP和PLGA)处理的缺损持续出现骨重建,而用缓慢溶解支架(HYAFF-11和PLLA)处理的缺损中只有三分之一出现骨组织。20周后,PLGA处理的缺损关节面出现纤维化的频率高于ACP处理的缺损。用缓慢溶解支架处理的缺损表面出现更多裂缝。
支架的降解速率对修复过程至关重要。缓慢溶解的支架在表面维持较厚的软骨组织,但经常出现裂缝和不连续。这些支架还会延迟缺损底部的骨形成。基于透明质酸的支架似乎能使细胞更快浸润,从而加快组织形成。ACP的降解导致快速骨形成,而HYAFF-11的缓慢降解延长了软骨的存在时间并延迟了软骨内骨形成。